✦ LIBER ✦

2.257 A double blind placebo controlled study of modafinil for Parkinson's disease related fatigue

✍ Scribed by H. Tyne; J. Brooks; J. Taylor; S. Vinjamuri; G. Baker; M. Steiger

Book ID: 117752909
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 66 KB
Volume: 13
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(08)70669-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa improves physical fatigue in Pa

Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study

✍ Jau-Shin Lou; Greg Kearns; Theodore Benice; Barry Oken; Gary Sexton; John Nutt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double‐blind, placebo‐controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Vi

Donepezil for dementia in Parkinson's di

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

✍ Ravina, B 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 90 KB

A double-blind, placebo-controlled trial

A double-blind, placebo-controlled trial of modafinil for cocaine dependence

✍ Charles A. Dackis; Kyle M. Kampman; Kevin G. Lynch; Jennifer G. Plebani; Helen M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 463 KB

A double-blind, placebo-controlled and l

A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease

✍ J Jankovic; C Hunter 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Botulinum toxin type A for drooling in P

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease

✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s